TIVDAK (tisotumab vedotin-tftv) for injection

TIVDAK is a tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. FDA approved tisotumab vedotin-tftv (brand name TIVDAK) is not (yet) registered or available in India but on request Indian patient can buy TIVDAK at the lowest price.

Home | tisotumab vedotin-tftv

TIVDAK-tisotumab-Price-India
TIVDAK (tisotumab vedotin-tftv) for injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

TIVDAK (tisotumab vedotin-tftv) for injection

Used for the Treatment of Cardiovascular Disease | Thrombotic/Thromboembolic Disorder | Cerebral Thrombosis/Embolism | Renal Vein Thrombosis | Pulmonary Thromboembolism | Thrombocythemia | Thromboembolic Pulmonary Hypertension

TIVDAK is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

Tisotumab vedotin-tftv is approved to treat: Cervical cancer that is recurrent or metastatic. It is used in women whose cancer got worse during or after treatment with chemotherapy.

Drug (Brand / Generic): TIVDAK / tisotumab vedotin-tftv
Current Indication: treat Cervical cancer 
Approval Date: Aug 1, 2017

For Injection: 40 mg as a lyophilized cake or powder in a single-dose vial for
reconstitution.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.